Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Top Story
Heart Disease
‘Good’ cholesterol worse for some adults: NIH study
In the study, lower levels of "good" cholesterol were associated with increased risks for heart attacks for white but not Black adults.
Featured
Molecular Diagnostics
DNA forensic evidence frees Ohio man of rape, attempted rape
Diabetes
Widespread HbA1c screening enables earlier type 2 diabetes diagnosis in U.K. study
Latest News
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
November 23, 2022
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
November 23, 2022
Biological Dynamics embarks on clinical utility studies for pancreatic cancer detection assay
November 23, 2022
FDA grants EUA for Lucira Health’s COVID-19 and flu combination test
November 23, 2022
Business Insights
Biosensors
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
Financial Results
Meridian Bioscience Q4 revenues drop 14% on lower COVID-19 testing, misses analysts' estimates
Accreditation
Castle Biosciences Pittsburgh laboratory receives CAP accreditation
Financial Results
Agilent Technologies Q4 revenues rise 11%
Diagnostic Technologies
Biosensors
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
COVID-19
FDA grants EUA for Lucira Health’s COVID-19 and flu combination test
Molecular Diagnostics
DNA forensic evidence frees Ohio man of rape, attempted rape
Biomarker Discovery & Validation
Biocare Medical acquires Empire Genomics to expand molecular biomarker portfolio
Diseases
Bladder Cancer
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
Pancreatic Cancer
Biological Dynamics embarks on clinical utility studies for pancreatic cancer detection assay
COVID-19
FDA grants EUA for Lucira Health’s COVID-19 and flu combination test
Prostate Cancer
Low-value prostate cancer screening has Medicare spending ramifications, study finds
More from LabPulse.com
Low-value prostate cancer screening has Medicare spending ramifications, study finds
The consequences of low-value PSA cancer screening could amount to more than $275 million in spending for Medicare, according to the authors' estimates.
November 22, 2022
Meridian Bioscience Q4 revenues drop 14% on lower COVID-19 testing, misses analysts' estimates
Diagnostics segment revenue growth was driven by nonmolecular assay products, which increased 22%.
November 22, 2022
Biocare Medical acquires Empire Genomics to expand molecular biomarker portfolio
The acquisition of Empire Genomics will expand Biocare Medical’s molecular biomarker portfolio substantially.
November 22, 2022
Qiagen adds monkeypox test to automated PCR platform
Addressing a need to improve surveillance of monkeypox, Qiagen announced that it has launched a research-use-only monkeypox test strip capable of detecting both variants of the virus.
November 22, 2022
Sense Biodetection inks deal for distribution of COVID-19 testing platform in the Netherlands, Belgium, Luxembourg
Sense Biodetection has signed a distribution deal with R-Biopharm Nederland, bringing its instrument-free platform for COVID-19 testing to the Benelux Union.
November 22, 2022
NIH website enables anonymous reporting of at-home COVID-19 test results
COVID-19 test results provide valuable data that public health departments can use to assess the needs and modify the responses in the local community, the state, or the nation, NIH noted.
November 22, 2022
Most Popular
DNA forensic evidence frees Ohio man of rape, attempted rape
Low-value prostate cancer screening has Medicare spending ramifications, study finds
‘Good’ cholesterol worse for some adults: NIH study
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
PerkinElmer launches adeno-associated virus vector detection kits for research
Widespread HbA1c screening enables earlier type 2 diabetes diagnosis in U.K. study
More from LabPulse.com
Johns Hopkins cell-free DNA blood test detects 80% of liver cancers in study
The researchers believe there is potential to leverage the technology to develop a commercial blood test to detect hepatocellular cancer with higher accuracy than current tests.
November 18, 2022
Chest publication suggests potential for MagArray blood test to stratify lung cancer risk
Its Knodule ID test is a multianalyte assay with algorithmic analysis comprising seven protein biomarkers and six clinical factors.
November 21, 2022
Castle Biosciences Pittsburgh laboratory receives CAP accreditation
All of Castle Biosciences' laboratories are now accredited by the College of American Pathologists.
November 21, 2022
Agilent Technologies Q4 revenues rise 11%
The Diagnostics and Genomics Group generated fourth-quarter revenue of $352 million, up 3% year-over-year.
November 21, 2022
PerkinElmer launches adeno-associated virus vector detection kits for research
The new kits use bead-based luminescent amplification to provide researchers with an option that is less time-consuming than ELISA and other wash-based tests, as well as having a wide detection range and high throughput.
November 21, 2022
Reagent supplier launches antigens for Southern Hemisphere's 2023 flu season
The hemagglutinin and neuraminidase antigens were developed in response to flu vaccine formulations the World Health Organization selected for development in the Southern Hemisphere.
November 21, 2022
